APA (7th ed.) Citation

Asangani, I. A., Wilder-Romans, K., Dommeti, V. L., Krishnamurthy, P. M., Apel, I. J., Escara-Wilke, J., . . . Chinnaiyan, A. M. (2016). BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer. Molecular cancer research, 14(4), 324-331. https://doi.org/10.1158/1541-7786.MCR-15-0472

Chicago Style (17th ed.) Citation

Asangani, Irfan A., et al. "BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer." Molecular Cancer Research 14, no. 4 (2016): 324-331. https://doi.org/10.1158/1541-7786.MCR-15-0472.

MLA (9th ed.) Citation

Asangani, Irfan A., et al. "BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer." Molecular Cancer Research, vol. 14, no. 4, 2016, pp. 324-331, https://doi.org/10.1158/1541-7786.MCR-15-0472.